Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZOE-LTFU long-term follow-up of HZ/su vaccine in older adults
2015-001778-17Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Zoster vaccine recombinant in herpes zoster (HZ) (4 arms), sponsored by GSK. Primary endpoint: Confirmed herpes zoster cases. Started Feb 2016; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2015-001778-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001778-17.